Document Type : Original Article
Authors
1 Department of Cardiovascular Surgery, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
2 Department of Biology, Faculty of Science, Payam-e Noor University of Mashhad, Mashhad, Iran
3 Department of anesthesiology, Faculty of medicine, Mashhad University of medical sciences, Mashhad, Iran
4 Department of Biology, Faculty of Science, Payam-e Noor University,Tehran, Iran
5 Clinical Research Development Unit, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
6 Razavi Cancer Research Center, Razavi Hospital, Imam Reza International University, Mashhad, Iran
Abstract
Keywords
Open Access Policy: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/
1. Meng F, Ma J, Wang W, Lin B. Meta-analysis of interleukin 6, 8, and 10 between offpump and on-pump coronary artery bypass groups. Bosn J Basic Med Sci. 2017 May; 17(2): 85-94. https://doi.org/10.17305/bjbms.2017.1505 PMid:28284177 PMCid:PMC5474113 |
||||
2. Brinkman WT, Squiers JJ, Covington KR, Wheeler DA, Arsalan M, Smith RL, et al. Mini-extracorporeal circulation and off-pump techniques associated with less inflammatory gene expression as compared to on-pump in the 24-hour postoperative window following coronary artery bypass grafting. J Cardiothorac Surg 2015;10(Suppl 1): A101. https://doi.org/10.1186/1749-8090-10-S1-A101 PMCid:PMC4693786 |
||||
3. Afilalo J, Rasti M, Ohayon SM, Shimony A, Eisenberg MJ. Offpump vs. On-pump coronary artery bypass surgery: An updated meta-analysis and meta-regression of randomized trials. Eur Heart J 2012;33(10):1257-67. https://doi.org/10.1093/eurheartj/ehr307 PMid:21987177 |
||||
4. Nesher N, Frolkis I, Vardi M, Sheinberg N, Bakir I, Caselman F, et al. Higher levels of serum cytokines and myocardial tissue markers during on-pump versus off-pump coronary artery bypass surgery. J Card Surg 2006;21(4):395-402. https://doi.org/10.1111/j.1540-8191.2006.00272.x PMid:16846420 |
||||
5. Wan IY, Arifi AA, Wan S, Yip JH, Sihoe AD, Thung KH, et al. Beating heart revascularization with or without cardiopulmonary bypass: Evaluation of inflammatory response in a prospective randomized study. J Thorac Cardiovasc Surg 2004;127(6):1624-31. https://doi.org/10.1016/j.jtcvs.2003.10.043 PMid:15173716 |
||||
6. Ghorbel MT, Cherif M, Mokhtari A, Bruno VD, Caputo M, Angelini GD. Off-pump coronary artery bypass surgery is associated with fewer gene expression changes in the human myocardium in comparison with on-pump surgery. Physiol Genomics 2010;42(1):67-75. https://doi.org/10.1152/physiolgenomics.00174.2009 PMid:20332183 PMCid:PMC2888559 |
||||
7. Rogers CA, Pike K, Angelini GD, Reeves BC, Glauber M, Ferrarini M, et al. An open randomized controlled trial of median sternotomy versus anterolateral left thoracotomy on morbidity and health care resource use in patients having off-pump coronary artery bypass surgery: The Sternotomy Versus Thoracotomy (STET) trial. J Thorac Cardiovasc Surg 2013;146(2):306-16.e9. https://doi.org/10.1016/j.jtcvs.2012.04.020 PMid:22944093 |
||||
8. Brocker C, Thompson D, Matsumoto A, Nebert DW, Vasiliou V. Evolutionary divergence and functions of the human interleukin (IL) gene family. Hum Genomics 2010;5(1):30-55. https://doi.org/10.1186/1479-7364-5-1-30 PMid:21106488 PMCid:PMC3390169 |
||||
9. Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B, et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003;421(6924):744-8. https://doi.org/10.1038/nature01355 PMid:12610626 |
||||
10. Kuilman T, Michaloglou C, Vredeveld LC, Douma S, van Doorn R, Desmet CJ, et al. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 2008;133(6):1019-31. https://doi.org/10.1016/j.cell.2008.03.039 PMid:18555778 |
||||
11. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF, et al. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998;101(2):311-20. https://doi.org/10.1172/JCI1368 PMid:9435302 PMCid:PMC508569 |
||||
12. 12. Andrew H, Lichtman, Shiv Pillai. Cellular and Molecular Immunology. Abul Abbas. Translators: Talibzadeh A, Bajan M, and Khalili A. Tehran: Khalili Publications, 2012. (Persian) | ||||
13. Vajgani M. Immunology. Tehran: Tehran University Jihad Organization Publications, 2016.(Persian)Shi C, Zhu L, Chen X, Gu N, Chen L, Zhu L, et al. IL-6 and TNF-a induced obesity-related inflammatory response through transcriptional regulation of miR-146b. J Interferon Cytokine Res 2014;34(5):342-8. https://doi.org/10.1089/jir.2013.0078 PMid:24428800 PMCid:PMC4015473 |
||||
14. Pickup JC, Mattock MB, Chusney GD, Burt D. NIDDM as a disease of the innate immune system: Association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997;40(11):1286-92. https://doi.org/10.1007/s001250050822 PMid:9389420 |
||||
15. Phillips CM, Perry IJ. Does inflammation determine metabolic health status in obese and nonobese adults? J Clin Endocrinol Metab 2013;98(10):E1610-9. https://doi.org/10.1210/jc.2013-2038 PMid:23979951 |
||||
16. Vozarova B, Weyer C, Lindsay RS, Pratley RE, Bogardus C, Tataranni PA. High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of Type 2 diabetes. Diabetes 2002;51(2):455-61. https://doi.org/10.2337/diabetes.51.2.455 PMid:11812755 |